Adjuvant therapy for patients with stage I papillary serous endometrial cancer.
Uterine papillary serous carcinoma (UPSC) is an aggressive variant of endometrial cancer characterized by a high recurrence rate and poor prognosis. Several studies have demonstrated that UPSC has a tendency to manifest with extra-uterine disease, even for tumors which appear to be limited to the endometrium. The data on adjuvant chemotherapy for stage I UPSC are limited, and the available studies are generally under-powered to assess if chemotherapy improves survival. However, we believe that, patients with UPSC should receive complete surgical staging, including omentectomy and peritoneal biopsies, and then until the results of larger series or randomized controlled trials will be available, we feel that combined radiotherapy and chemotherapy is justified for all stage I UPSC.
Alobaid
A
A
Gynecologic Oncology Service, Centre hospitalier de l'Université de Montréal (CHUM), Hôpital Notre-Dame, Montreal, Quebec, Canada H2L 4M1
Bruchim
I
I
Verkooijen
H
H
Gauthier
P
P
Petignat
P
P
D003131:Combined Modality Therapy; D018284:Cystadenocarcinoma, Serous / Q000473:pathology / Q000628:therapy*; D016889:Endometrial Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D013997:Time Factors; D016896:Treatment Outcome